Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Sea Pharmaceuticals, LLC

Advertisement

Advertisement

14 Gray St
Cambridge, MA 02138

Sea Pharmaceuticals, LLC is a research and development company based in Cambridge, MA. Specializing in pharmaceutical innovation, the company focuses on developing cutting-edge treatments for a range of medical conditions.

With a team of dedicated scientists and researchers, Sea Pharmaceuticals, LLC is committed to advancing the field of medicine through groundbreaking discoveries and advancements in drug development. Their work aims to improve patient outcomes and contribute to the overall health and well-being of individuals worldwide.

Generated from their business information

Also at this address

Harvard University

Own this business?
Claim it
See a problem?

You might also like

Drugs and drug proprietaries

Matrivax Research & Development Corporation

Matrivax Research & Development Corporation is a Boston-based company that is dedicated to developing life-saving vaccines to combat pneumococcal disease and Clostridiodes difficile infections. With a focus on breakthrough science, they are working on a next-generation pneumococcal vaccine to significantly reduce the global impact of this disease, which still causes over 1,000,000 deaths annually worldwide. Additionally, they are developing a novel C. difficile vaccine that targets both the bacteria and toxins, aiming to prevent bacterial colonization and toxicity, addressing the urgent public health threat posed by this infection that causes an estimated half a million infections in the US alone.Generated from the website
Cancer hospital, Services, nec, nec, Feathers and feather products

NovoBiotic Pharmaceuticals, LLC

NovoBiotic Pharmaceuticals, LLC is a biotechnology company based in Cambridge, MA, specializing in the discovery and development of novel antibiotics. The company's research focuses on identifying unique microbial compounds with potential therapeutic applications. Utilizing cutting-edge technology and innovative approaches, NovoBiotic Pharmaceuticals aims to address the growing global health challenge of antibiotic resistance. The company is committed to advancing the field of antibiotic discovery to combat infectious diseases and improve public health outcomes. Generated from their business information
Sizes, Drugs acting on the respiratory system, Business services, nec, nec

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Cambridge›Sea Pharmaceuticals, LLC

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell